Neuropsychopharmacology (journal)
peer-reviewed scientific journal
Neuropsychopharmacology is a monthly peer-reviewed scientific journal published by Nature Portfolio. It was established in 1987 and is an official publication of the American College of Neuropsychopharmacology. The journal covers all aspects of neuropsychopharmacology, including clinical and basic science research into the brain and behavior, the properties of agents acting within the central nervous system, and drug targeting and development. In addition to primary articles and reviews, the journal publishes Brainpod, a podcast highlighting content published in the journal and featuring interviews with the authorship team.
Editors-in-chief
Over the years, there have been ten editors-in-chief ("principal editors"), including J. Christian Gillin (1987-1993), Ronald D. Ciaranello (1994), Herbert Y. Meltzer (1994-1998), Hans C. Fibiger (1995-1998), Robert H. Lenox (1999-2001), Charles B. Nemeroff (2002-2006), and James H. Meador-Woodruff (2007-2012) and William A. Carlezon, Jr. (2013-2022). Since 2023, Tony P. George (University of Toronto) and Lisa M. Monteggia (Vanderbilt University) have been co-editors.
Abstracting and indexing
The journal is abstracted and indexed in:
According to the Journal Citation Reports, the journal has a 2024 impact factor of 7.1.
Begin with the source’s own compact description: “Neuropsychopharmacology (journal)” is peer-reviewed scientific journal. The dossier treats that line as a proposition to test through Neuropsychopharmacology, journal and peer-reviewed, not as a finished interpretation.
Why this record matters
The phrase “peer-reviewed scientific journal” supplies a clear boundary for inquiry. It also exposes the unanswered questions: who defined that boundary, when it became stable and which sources sit outside it.
The date and method of observation matter as much as the stated conclusion, especially where classification or consensus has changed. The source revision retrieved here is dated Feb 19, 2026. The linked authority identifier is Q2261280. 8 of 8 selected statements include explicit references; 1 carry qualifiers and 0 use preferred rank. The first chronological checks are 1987, 1993, 1994 and 1998.
A general summary may omit uncertainty, sample limits or methodological disagreement that is explicit in the technical record. The lead is largely declarative, so disagreement and counter-evidence require a deliberate search beyond the opening account. Authority statements aid reconciliation but still require their own references, qualifiers and ranks to be checked.
How to read it
Check terminology, classification and the date of the cited evidence. Scientific names and technical consensus can change while older records retain historical value.
- Current terminology
- Classification context
- Finding cited technical literature
Primary datasets, specimen catalogues, standards bodies and the most recent peer-reviewed literature.
Three-step research path
- Establish the record: confirm the title “Neuropsychopharmacology (journal)”, its source revision and the description used here.
- Expand the search: follow Neuropsychopharmacology (journal) primary sources, Neuropsychopharmacology (journal) archive and Neuropsychopharmacology research across catalogues and specialist indexes.
- Test the account: compare the strongest cited source with the responsible institution’s current record and note any disagreement.
Questions for further research
- Which source most directly establishes the central claim about “Neuropsychopharmacology (journal)”?
- Is the terminology current, historical or disputed?
- Which observation, specimen, dataset or publication supports the account?
Search terms from this dossier
This entry incorporates text from “Neuropsychopharmacology (journal)” on English Wikipedia. Contributors are listed in the page history. Text is available under the Creative Commons Attribution-ShareAlike 4.0 License. Selected authority identifiers and statements are retrieved from Wikidata under CC0; their references and qualifiers remain part of the verification path.